Novartis Closes Plant, 450 Lose Jobs

Oct 17, 2017

The Denver Post

Novartis announced it is closing its Sandoz generic-drug manufacturing division in Broomfield, Colorado, according to The Denver Post. The decision will cause 450 local jobs to be eliminated over a two-year period.

The company said “double-digit price erosion caused by customer consolidation and increased competition taking place within the U.S. generic drug market” caused Novartis to face above-average pricing pressure in the United States, the story said.

Novartis spokesperson Sofina Mirza-Reid said the phased closure and transfer of operations to Wilson, N.C., will be complete in the fourth quarter of 2019.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments